CYP1B1 and cancer: Given the lack of connection between the mechanisms of action of these essential drugs, which form the foundation of the vast majority of chemotherapy regimens, CYP1B1-mediated resistance may be negatively impacting treatment outcomes for most cancer patients who receive chemotherapy.